We are live on
!
Find out more
Fayez Sarofim & Co Portfolio holdings
AUM
$39.1B
1-Year Est. Return
15.14%
This Fund
S&P 500
This Quarter
Est. Return
+1.04%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$18.4B
AUM Growth
+$120M
(+0.66%)
Cap. Flow
+$64.5M
Cap. Flow
% of AUM
0.35%
Top 10 Holdings %
Top 10 Hldgs %
43.98%
Holding
252
New
8
Increased
28
Reduced
110
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$285M |
| 2 |
UnitedHealth
UNH
|
+$53.5M |
| 3 |
GE Aerospace
GE
|
+$36.4M |
| 4 |
PepsiCo
PEP
|
+$12.5M |
| 5 |
Ralph Lauren
RL
|
+$10.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$39.4M |
| 2 |
Philip Morris
PM
|
+$20.6M |
| 3 |
Apple
AAPL
|
+$18.7M |
| 4 |
Coca-Cola
KO
|
+$17.7M |
| 5 |
Altria Group
MO
|
+$13.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 31.84% |
| 2 | Energy | 18.16% |
| 3 | Financials | 14.69% |
| 4 | Healthcare | 10.53% |
| 5 | Technology | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Walt Disney
DIS
$171B
| $216M | 1.18% |
2,331,515
-51,927
| -2% | -$4.97M |
|
27
Blackrock
BLK
$167B
| $212M | 1.15% |
584,610
-19,134
| -3% | -$6.96M |
|
|
EV
28
DELISTED
Eaton Vance Corp.
EV
| $201M | 1.1% |
5,160,000
| – | – |
|
29
Merck
MRK
$322B
| $196M | 1.07% |
3,291,417
-19,986
| -0.6% | -$1.17M |
|
30
Kraft Heinz
KHC
$32.8B
| $195M | 1.06% |
2,179,352
+860
| +0% | +$76.1K |
|
31
State Street
STT
$48.4B
| $193M | 1.05% |
2,766,410
-81,358
| -3% | -$5.32M |
|
32
Alphabet (Google) Class C
GOOG
$4.11T
| $188M | 1.02% |
4,836,720
-106,520
| -2% | -$4.04M |
|
33
Occidental Petroleum
OXY
$55.7B
| $174M | 0.95% |
2,388,117
-114,673
| -5% | -$8.58M |
|
34
Union Pacific
UNP
$174B
| $173M | 0.94% |
1,772,808
-53,954
| -3% | -$5.05M |
|
|
PX
35
DELISTED
Praxair Inc
PX
| $170M | 0.92% |
1,402,875
-46,225
| -3% | -$5.47M |
|
36
American Express
AXP
$224B
| $168M | 0.92% |
2,631,873
+106,544
| +4% | +$6.84M |
|
37
Visa
V
$701B
| $167M | 0.91% |
2,019,411
+22,354
| +1% | +$1.79M |
|
38
RTX Corp
RTX
$290B
| $166M | 0.9% |
2,591,438
-93,066
| -3% | -$6.17M |
|
39
Estee Lauder
EL
$30.4B
| $165M | 0.9% |
1,868,182
-59,367
| -3% | -$5.41M |
|
40
ConocoPhillips
COP
$144B
| $161M | 0.87% |
3,697,130
-85,880
| -2% | -$3.57M |
|
41
S&P Global
SPGI
$124B
| $142M | 0.77% |
1,124,587
-22,720
| -2% | -$2.73M |
|
42
Target
TGT
$66.3B
| $142M | 0.77% |
2,071,165
-140,206
| -6% | -$10M |
|
43
AB InBev
BUD
$164B
| $137M | 0.75% |
1,045,218
-36,883
| -3% | -$4.66M |
|
44
Canadian Pacific Kansas City
CP
$81B
| $124M | 0.67% |
4,045,830
-128,165
| -3% | -$3.76M |
|
45
Novartis
NVS
$302B
| $123M | 0.67% |
1,736,781
-56,875
| -3% | -$4.14M |
|
46
Plains All American Pipeline
PAA
$17.6B
| $119M | 0.65% |
3,786,043
-16,850
| -0.4% | -$482K |
|
47
Gilead Sciences
GILD
$165B
| $111M | 0.61% |
1,407,967
-45,723
| -3% | -$3.71M |
|
48
Automatic Data Processing
ADP
$109B
| $109M | 0.59% |
1,230,704
-32,100
| -3% | -$2.91M |
|
49
TotalEnergies
TTE
$193B
| $100M | 0.55% |
2,101,604
-146,550
| -7% | -$7M |
|
|
TFCFA
50
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $93M | 0.51% |
3,824,767
-122,399
| -3% | -$3.13M |
|
Similar funds
HF
Fayez Sarofim & Co's Q3 2016 Portfolio in Review
As of Q3 2016, Fayez Sarofim & Co held 252 positions worth $18.4B, up 0.66% from $18.3B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Trading was light in Q3 2016: portfolio turnover was 4.8%. Fayez Sarofim & Co opened 8 new positions and exited 4, leaving the 252-position portfolio largely intact.
By sector, the portfolio is most concentrated in Consumer Staples at 32% of assets, down from 34% a quarter earlier, followed by Energy and Financials.
- Fayez Sarofim & Co's largest Q3 2016 buy was UnitedHealth: 381,762 shares worth $53.3M.
- Fayez Sarofim & Co added most to ExxonMobil in Q3 2016, an estimated $285M increase.
- Fayez Sarofim & Co's biggest Q3 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $39.4M.
- Fayez Sarofim & Co fully exited Rio Tinto in Q3 2016, selling an estimated $382K.
- Fayez Sarofim & Co's ten largest holdings make up 44% of its $18.4B portfolio in Q3 2016.
- Fayez Sarofim & Co opened 8 new positions and closed 4 in Q3 2016.
- Fayez Sarofim & Co's portfolio value rose 0.66% quarter-over-quarter to $18.4B.
Based on Fayez Sarofim & Co's 13F filing for Q3 2016, filed 14 Nov 2016.